Liquid embolic material for the treatment of small vessel hemmorhage

Project Summary/Abstract In my current ESI-R01, we developed a biomaterial to treat acute hemorrhage via transcatheter embolization to block large arteries (>3 mm). This was FDA-approved on 7/2022 and has already saved many lives. It represents the first intra-vascular injectable biomaterial approved by FDA. In this renewal, we will build upon our experience and address acute hemorrhage resulting from small blood vessels